Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
about
Twenty-First Century Diseases: Commonly Rare and Rarely Common?Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells.Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.New insights into cell-based therapy for heart failure from the CHART-1 study.Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
P2860
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
@en
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
@nl
type
label
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
@en
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
@nl
prefLabel
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
@en
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
@nl
P2093
P2860
P356
P1476
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
@en
P2093
Adam Mendizabal
Aisha Khan
Alan W Heldman
Ana Marie Landin
Anthony A Oliva
Audrey Medina
Bradley J Goldstein
Bryon A Tompkins
Cindy Delgado
Courtney Premer
P2860
P304
P356
10.1093/GERONA/GLX056
P407
P577
2017-10-01T00:00:00Z